VSTM5
gene geneOn this page
Also known as LOC387804
Summary
VSTM5 (V-set and transmembrane domain containing 5, HGNC:34443) is a protein-coding gene on chromosome 11q21, encoding V-set and transmembrane domain-containing protein 5 (A8MXK1). Cell adhesion-like membrane protein of the central nervous system (CNS) which modulates both the position and complexity of central neurons by altering their membrane morphology and dynamics.
Predicted to be involved in several processes, including filopodium assembly; positive regulation of excitatory synapse assembly; and protein homooligomerization. Predicted to be located in membrane. Predicted to be active in axon; dendrite; and plasma membrane.
Source: NCBI Gene 387804 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_001144871
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34443 |
| Approved symbol | VSTM5 |
| Name | V-set and transmembrane domain containing 5 |
| Location | 11q21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC387804 |
| Ensembl gene | ENSG00000214376 |
| Ensembl biotype | protein_coding |
| OMIM | 621118 |
| Entrez | 387804 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron
ENST00000398221, ENST00000409977, ENST00000414919, ENST00000960694
RefSeq mRNA: 1 — MANE Select: NM_001144871
NM_001144871
CCDS: CCDS44709
Canonical transcript exons
ENST00000409977 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001532182 | 93820743 | 93820883 |
| ENSE00001532183 | 93820997 | 93821323 |
| ENSE00001577951 | 93850412 | 93850618 |
| ENSE00001582531 | 93818232 | 93820612 |
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 90.14.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2069 / max 21.0693, expressed in 93 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 121839 | 0.2069 | 93 |
Top tissues by expression
131 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 90.14 | gold quality |
| quadriceps femoris | UBERON:0001377 | 85.72 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.48 | gold quality |
| thymus | UBERON:0002370 | 80.01 | silver quality |
| placenta | UBERON:0001987 | 76.53 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.54 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.42 | gold quality |
| primary visual cortex | UBERON:0002436 | 72.51 | gold quality |
| hypothalamus | UBERON:0001898 | 72.02 | gold quality |
| frontal cortex | UBERON:0001870 | 71.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.63 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.54 | gold quality |
| cerebral cortex | UBERON:0000956 | 69.24 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.16 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 66.61 | gold quality |
| rectum | UBERON:0001052 | 65.79 | gold quality |
| stromal cell of endometrium | CL:0002255 | 63.83 | gold quality |
| Ammon’s horn | UBERON:0001954 | 62.77 | gold quality |
| substantia nigra | UBERON:0002038 | 62.68 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 62.57 | gold quality |
| brain | UBERON:0000955 | 62.48 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 62.19 | gold quality |
| temporal lobe | UBERON:0001871 | 62.00 | gold quality |
| amygdala | UBERON:0001876 | 61.84 | gold quality |
| transverse colon | UBERON:0001157 | 60.80 | gold quality |
| cortical plate | UBERON:0005343 | 60.69 | gold quality |
| colon | UBERON:0001155 | 60.43 | gold quality |
| body of stomach | UBERON:0001161 | 59.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 59.67 | gold quality |
| intestine | UBERON:0000160 | 59.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.93 |
Regulation
Is transcription factor: no
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkeyp-97a10.3 | ENSDARG00000104656 |
| mus_musculus | Vstm5 | ENSMUSG00000031937 |
| rattus_norvegicus | Vstm5 | ENSRNOG00000010480 |
Paralogs (24): CEACAM21 (ENSG00000007129), CEACAM7 (ENSG00000007306), CEACAM1 (ENSG00000079385), CEACAM6 (ENSG00000086548), CEACAM4 (ENSG00000105352), CEACAM5 (ENSG00000105388), PSG8 (ENSG00000124467), CEACAM8 (ENSG00000124469), HEPACAM (ENSG00000165478), PSG6 (ENSG00000170848), CEACAM3 (ENSG00000170956), PSG9 (ENSG00000183668), CEACAM19 (ENSG00000186567), HEPACAM2 (ENSG00000188175), PSG5 (ENSG00000204941), CEACAM18 (ENSG00000213822), CEACAM16 (ENSG00000213892), PSG3 (ENSG00000221826), PSG7 (ENSG00000221878), PSG1 (ENSG00000231924), PSG2 (ENSG00000242221), PSG11 (ENSG00000243130), PSG4 (ENSG00000243137), CEACAM20 (ENSG00000273777)
Protein
Protein identifiers
V-set and transmembrane domain-containing protein 5 — A8MXK1 (reviewed: A8MXK1)
All UniProt accessions (2): A8MXK1, H0Y3Q1
UniProt curated annotations — full annotation on UniProt →
Function. Cell adhesion-like membrane protein of the central nervous system (CNS) which modulates both the position and complexity of central neurons by altering their membrane morphology and dynamics. Involved in the formation of neuronal dendrites and protrusions including dendritic filopodia. In synaptogenesis, regulates synapse formation by altering dendritic spine morphology and actin distribution. Promotes formation of unstable neuronal spines such as thin and branched types. Regulates neuronal morphogenesis and migration during cortical development in the brain.
Subunit / interactions. Can homooligomerize through cis interactions within the same cell membrane.
Subcellular location. Cell membrane. Cell projection. Dendrite. Axon.
Post-translational modifications. N-glycosylated.
RefSeq proteins (1): NP_001138343* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003599 | Ig_sub | Domain |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR015631 | CD2/SLAM_rcpt | Family |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
UniProt features (8 total): topological domain 2, signal peptide 1, chain 1, transmembrane region 1, domain 1, region of interest 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MXK1-F1 | 88.18 | 0.64 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 102
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 51 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, GOBP_SYNAPSE_ASSEMBLY, GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY, GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY, GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT, GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOBP_CELL_JUNCTION_ORGANIZATION, GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY, GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY, GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY, GOBP_PROTEIN_HOMOOLIGOMERIZATION, GOBP_CELL_JUNCTION_ASSEMBLY
GO Biological Process (5): immune response (GO:0006955), ventral spinal cord development (GO:0021517), filopodium assembly (GO:0046847), protein homooligomerization (GO:0051260), positive regulation of excitatory synapse assembly (GO:1904891)
GO Molecular Function (0):
GO Cellular Component (5): plasma membrane (GO:0005886), membrane (GO:0016020), axon (GO:0030424), dendrite (GO:0030425), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| neuron projection | 2 |
| immune system process | 1 |
| response to stimulus | 1 |
| spinal cord development | 1 |
| anatomical structure development | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| protein complex oligomerization | 1 |
| positive regulation of synapse assembly | 1 |
| excitatory synapse assembly | 1 |
| regulation of excitatory synapse assembly | 1 |
| membrane | 1 |
| cell periphery | 1 |
| dendritic tree | 1 |
Protein interactions and networks
STRING
172 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| VSTM5 | BKGD | Q9H0W9 | 585 |
| VSTM5 | SMCO4 | Q9NRQ5 | 564 |
| VSTM5 | GPR176 | Q14439 | 546 |
| VSTM5 | VWA5B1 | Q5TIE3 | 542 |
| VSTM5 | GPR75 | O95800 | 530 |
| VSTM5 | MED17 | Q9NVC6 | 527 |
| VSTM5 | GALR1 | P47211 | 458 |
| VSTM5 | HEPHL1 | Q6MZM0 | 450 |
| VSTM5 | MTMR12 | Q9C0I1 | 421 |
| VSTM5 | DHRS7C | A6NNS2 | 420 |
| VSTM5 | ANKRD55 | Q3KP44 | 408 |
| VSTM5 | KCNIP4 | Q6PIL6 | 386 |
| VSTM5 | LRRN2 | O75325 | 380 |
| VSTM5 | LARGE2 | Q8N3Y3 | 366 |
| VSTM5 | TM4SF5 | O14894 | 348 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A2AIG8, A5D7H1, A6H7A0, A6NFX1, A6NJW4, A8MUP2, A8MXK1, B0BMW8, O35393, O54804, O73884, P01135, P35790, P52875, P57791, Q00961, Q01098, Q01134, Q06922, Q08DW9, Q0P5M9, Q0VDI3, Q14728, Q14957, Q15768, Q2M1K6, Q3UGX3, Q4R7M4, Q4V899, Q5E9H2, Q5M7U7, Q5R6I6, Q5RCI5, Q5ZI20, Q7TPB4, Q8BZH0, Q8IVW8, Q8N431, Q8NBA8, Q8R2R5
Diamond homologs: A8MXK1, Q5M7U7, Q9D806, Q29RR6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
510 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:93850408:TTACT:T | donor_loss | 1.0000 |
| 11:93850410:A:AC | donor_gain | 1.0000 |
| 11:93850411:C:CC | donor_gain | 1.0000 |
| 11:93850411:CT:C | donor_gain | 1.0000 |
| 11:93850411:CTCTG:C | donor_gain | 1.0000 |
| 11:93820613:C:CC | acceptor_gain | 0.9900 |
| 11:93820991:TCTTA:T | donor_loss | 0.9900 |
| 11:93820992:CTTA:C | donor_loss | 0.9900 |
| 11:93820993:TTA:T | donor_loss | 0.9900 |
| 11:93820994:TA:T | donor_loss | 0.9900 |
| 11:93820995:A:AC | donor_gain | 0.9900 |
| 11:93820995:ACC:A | donor_loss | 0.9900 |
| 11:93820996:C:CC | donor_gain | 0.9900 |
| 11:93820996:C:CT | donor_loss | 0.9900 |
| 11:93850410:ACT:A | donor_gain | 0.9900 |
| 11:93850411:CTC:C | donor_gain | 0.9900 |
| 11:93850411:CTCT:C | donor_gain | 0.9900 |
| 11:93820609:CTTT:C | acceptor_gain | 0.9800 |
| 11:93820610:TTT:T | acceptor_gain | 0.9800 |
| 11:93820611:TTC:T | acceptor_loss | 0.9800 |
| 11:93820612:TC:T | acceptor_loss | 0.9800 |
| 11:93820613:CT:C | acceptor_loss | 0.9800 |
| 11:93820614:T:A | acceptor_loss | 0.9800 |
| 11:93820882:CT:C | acceptor_gain | 0.9800 |
| 11:93820884:C:CC | acceptor_gain | 0.9800 |
| 11:93820897:G:C | acceptor_gain | 0.9800 |
| 11:93820990:GTCTT:G | donor_loss | 0.9800 |
| 11:93820883:TC:T | acceptor_loss | 0.9700 |
| 11:93820884:CT:C | acceptor_loss | 0.9700 |
| 11:93820885:T:C | acceptor_loss | 0.9700 |
AlphaMissense
1300 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:93821216:A:G | W67R | 0.997 |
| 11:93821216:A:T | W67R | 0.997 |
| 11:93821105:A:G | S104P | 0.994 |
| 11:93821214:C:A | W67C | 0.992 |
| 11:93821214:C:G | W67C | 0.992 |
| 11:93821174:A:G | W81R | 0.990 |
| 11:93821174:A:T | W81R | 0.990 |
| 11:93821107:C:T | G103D | 0.988 |
| 11:93821172:C:A | W81C | 0.988 |
| 11:93821172:C:G | W81C | 0.988 |
| 11:93821215:C:G | W67S | 0.985 |
| 11:93820807:G:C | S165R | 0.983 |
| 11:93820807:G:T | S165R | 0.983 |
| 11:93820809:T:G | S165R | 0.983 |
| 11:93821107:C:A | G103V | 0.983 |
| 11:93821108:C:G | G103R | 0.979 |
| 11:93821063:A:C | Y118D | 0.978 |
| 11:93821101:A:T | I105N | 0.977 |
| 11:93821251:A:T | V55D | 0.975 |
| 11:93821095:A:G | L107P | 0.973 |
| 11:93821109:G:C | N102K | 0.972 |
| 11:93821109:G:T | N102K | 0.972 |
| 11:93821074:T:A | D114V | 0.971 |
| 11:93821002:A:T | V138D | 0.970 |
| 11:93821074:T:G | D114A | 0.969 |
| 11:93821104:G:A | S104F | 0.969 |
| 11:93821115:A:C | F100L | 0.969 |
| 11:93821115:A:T | F100L | 0.969 |
| 11:93821117:A:G | F100L | 0.969 |
| 11:93821075:C:G | D114H | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000120295 (11:93850833 A>T), RS1000187537 (11:93849362 G>A), RS1000270798 (11:93826406 CT>C,CTT), RS1000316950 (11:93838794 T>C), RS1000319998 (11:93843134 C>G,T), RS1000361346 (11:93820394 C>A,T), RS1000417555 (11:93848680 T>C,G), RS1000423650 (11:93850560 C>G,T), RS1000424132 (11:93832939 G>C), RS1000704146 (11:93843354 G>A,T), RS1000781902 (11:93837921 A>G), RS1000910053 (11:93818762 C>T), RS1001025652 (11:93849275 G>A), RS1001122621 (11:93826612 G>A), RS1001126391 (11:93825374 T>C,G)
Disease associations
OMIM: gene MIM:621118 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Smoke | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.